Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
Patricio Gonzalez-Hormazabal1, Maher Musleh2, Marco Bustamante3
1Human Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago 8380453, Chile. patriciogonzalez@uchile.cl.
Abstract:
The RAS/RAF/MEK/ERK pathway regulates certain cellular functions, including cell proliferation, differentiation, survival, and apoptosis. Dysregulation of this pathway leads to the occurrence and progression of cancers mainly by somatic mutations. This study aimed to assess if polymorphisms of the RAS/RAF/MEK/ERK pathway are associated with gastric cancer. A case-control study of 242 gastric cancer patients and 242 controls was performed to assess the association of 27 single nucleotide polymorphisms (SNPs) in the RAS/RAF/MEK/ERK pathway genes with gastric cancer. Analyses performed under the additive model (allele) showed four significantly associated SNPs: RAF1 rs3729931 (Odds ratio (OR) = 1.54, 95%, confidence interval (CI): 1.20⁻1.98, p-value = 7.95 × 10-4), HRAS rs45604736 (OR = 1.60, 95% CI: 1.16⁻2.22, p-value = 4.68 × 10-3), MAPK1 rs2283792 (OR = 1.45, 95% CI: 1.12⁻1.87, p-value = 4.91 × 10-3), and MAPK1 rs9610417 (OR = 0.60, 95% CI: 0.42⁻0.87, p-value = 6.64 × 10-3). Functional annotation suggested that those variants or their proxy variants may have a functional effect. In conclusion, this study suggests that RAF1 rs3729931, HRAS rs45604736, MAPK1 rs2283792, and MAPK1 rs9610417 are associated with gastric cancer.
Insights
Genetic variations in the RAS/RAF/MEK/ERK pathway are linked to gastric cancer risk. Four specific single nucleotide polymorphisms (SNPs) in RAF1, HRAS, and MAPK1 genes show significant associations with this cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The RAS/RAF/MEK/ERK pathway is crucial for cellular functions like proliferation and survival.
- Dysregulation of this pathway, often due to somatic mutations, contributes to cancer development and progression.
- Understanding genetic predispositions, such as single nucleotide polymorphisms (SNPs), is vital for cancer research.
Purpose of the Study:
- To investigate the association between polymorphisms in the RAS/RAF/MEK/ERK pathway genes and gastric cancer.
- To identify specific SNPs within this pathway that may confer susceptibility or protection against gastric cancer.
Main Methods:
- A case-control study was conducted involving 242 gastric cancer patients and 242 healthy controls.
- Genotyping was performed for 27 single nucleotide polymorphisms (SNPs) within the RAS/RAF/MEK/ERK pathway.
- Statistical analyses, including the additive model, were used to assess the association between SNPs and gastric cancer risk.
Main Results:
- Four SNPs demonstrated a significant association with gastric cancer under the additive model.
- These include RAF1 rs3729931 (OR=1.54), HRAS rs45604736 (OR=1.60), MAPK1 rs2283792 (OR=1.45), and MAPK1 rs9610417 (OR=0.60).
- Functional annotation suggested potential functional roles for these identified variants or their proxies.
Conclusions:
- The study identifies specific SNPs in RAF1, HRAS, and MAPK1 genes as potentially associated with gastric cancer.
- These findings contribute to understanding the genetic basis of gastric cancer and the role of the RAS/RAF/MEK/ERK pathway.
- Further research into the functional impact of these SNPs could offer insights into gastric cancer etiology and prevention.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Single Nucleotide Polymorphisms-SNPs
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

